Cherie J. Katin

Cherie J. Katin serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements development through contract award and administration. Her role is central to ensuring compliance with the Federal Acquisition Regulation (FAR) while supporting mission-critical procurement needs within a highly regulated technical environment. She routinely handles complex contracts for scientific, laboratory, and biomedical infrastructure, balancing regulatory rigor with operational efficiency to deliver essential goods and services. Her acquisitions span high-value technical equipment, specialized manufacturing, and logistics solutions critical to public health and research operations. While specific contractor names are not available, Katin maintains consistent working relationships with a diverse pool of vendors specializing in biological product manufacturing, analytical instrumentation, and refrigerated storage. Her procurement approach emphasizes technical competency, regulatory adherence, and performance-based contracting, fostering partnerships with firms capable of meeting stringent quality and compliance standards. She engages both large-capacity manufacturers and niche suppliers to ensure reliable supply chain resilience and technical innovation across her portfolio. Katin’s contracting patterns reflect a strong preference for unrestricted competitions, with 94.9% of awards issued under non-set-aside authorities. However, she actively supports small business participation, allocating 5.1% of awards to Total Small Business Set-Asides under FAR 19.5. This reflects a measured commitment to socioeconomic goals without compromising mission requirements, demonstrating a balanced approach that prioritizes competition while ensuring eligible small businesses have meaningful access to opportunities. Her primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing), where she procures advanced biologics, reagents, and related production systems. She also frequently acquires analytical laboratory instruments (NAICS 334516) and refrigerated logistics services (NAICS 493120), indicating deep expertise in life sciences infrastructure. Her technical domain spans pharmaceutical manufacturing, clinical diagnostics, and cold-chain logistics, positioning her as a specialist in high-compliance, science-driven acquisitions.